SMAD7 and hepatocellular carcinoma: miR-216a/217 cluster was identified to be upregulated in recurrent HCC tissue samples and activated TGF-β and PI3K/AKT signaling by targeting SMAD family member 7 (SMAD7) and PTEN, respectively [154].